You are here

Bioiberica is recognized for their good management of occupational risk prevention

19 May 2015
Bioiberica

The reduction in our Social Security contributions for professional contingencies provides evidence that Bioiberica put a great effort in reducing workplace accidents 

Bioiberica, a biotech firm specializing in the research, development, production and marketing of bio-molecules for the pharmaceutical, veterinary and agrochemical industry, has received recognition for their management of occupational risks prevention.

The reduction in our Social Security contributions for professional contingencies provides evidence that Bioiberica put a great effort in reducing workplace accidents by means of measurable investments and implementing policy and practical measures at all levels in the company.

The bonus is granted by the General Directorate of the Social Security through Asepeyo, a social security collaborative entity, after checking that all requirements are met: facility investments, equipment for labor risk prevention, adequate security training, and maintaining a low level of working accidents during that period, which was in 2012 .

Asepeyo will host an event in Barcelona to recognize this achievement by Bioiberica. Our company will be represented by Gonzalo Arza, head of the occupational risk prevention department. Bioiberica attaches great importance to the prevention of occupational risks by implementing health and labor security policies for all their workers, which plays a key role in guaranteeing the social and economical benefits deriving from improved productivity and competitiveness. 

Related News

23 Jan 2024
Bioiberica

On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.

16 Oct 2023
Bioiberica

We participated in CPHI 2023 in Barcelona, ​​where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.

4 May 2023
Bioiberica

They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs

Bioiberica